Detalles del proyecto
| Estado | Finalizado |
|---|---|
| Fecha de inicio/Fecha fin | 10/10/18 → 3/7/25 |
Financiación
- Celgene International II Sarl: 142.266,00 US$
Induction Study #1 - A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Sudy of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
- Flomenhoft, Deborah (PI)